Location History:
- Weston, MA (US) (2010 - 2011)
- Collonges sous Salève, FR (2011)
- Colonges-sous-Saleve, FR (2008 - 2012)
Company Filing History:
Years Active: 2008-2012
Title: Michel Dreano: Innovator in Diabetic Neuropathy Treatment
Introduction
Michel Dreano is a notable inventor based in Collonges-sous-Saleve, France. He has made significant contributions to the field of medicine, particularly in the treatment of diabetic neuropathy. With a total of 5 patents to his name, Dreano's work focuses on innovative therapeutic approaches that leverage the body's signaling mechanisms.
Latest Patents
Among his latest patents, one significant invention is the "Use of gp130 activators in diabetic neuropathy." This invention relates to the use of a substance that signals through gp130 for the manufacture of a medicament aimed at treating and/or preventing diabetic neuropathy, with a preference for using IL-6. Another important patent is the "Method for inhibiting a microvascular complication by administering IL-6." This invention involves the use of IL-6 or its derivatives in addressing microvascular complications, showcasing Dreano's commitment to advancing medical treatments.
Career Highlights
Throughout his career, Michel Dreano has worked with prominent companies in the pharmaceutical industry, including Merck Serono S.A. and Laboratoires Serono S.A. His experience in these organizations has undoubtedly contributed to his innovative thinking and the development of his patents.
Collaborations
Dreano has collaborated with notable professionals in his field, including Pierre-Alain Vitte and Guido Tiberio. These partnerships have likely enriched his research and development efforts, leading to impactful inventions.
Conclusion
Michel Dreano's contributions to the field of diabetic neuropathy treatment through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical therapies, demonstrating the importance of innovation in healthcare.